Regeneron
REGENERON ANNOUNCES ENCOURAGING TOPLINE PHASE 2 DATA OF HIGH-DOSE AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION TARRYTOWN, N.Y., Aug. 24, 2021 /PRNewswire/ — Phase 3 trials in wet AMD and diabetic macular edema…
Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions
Click Here To Save Now